Medical News

Add to Favorites Subscribe Share
newswise-fb-share-
Press "esc" to clear
Go to Advanced Search
Showing results 1120 of 107837
Embargo will expire:
18-Feb-2019 2:00 PM EST
Released to reporters:
15-Feb-2019 10:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Feb-2019 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-Feb-2019 9:00 AM EST
Released to reporters:
15-Feb-2019 9:40 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Feb-2019 9:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

APS_logo.gif

Article ID: 708153

American Pain Society Scientific Meeting, April 3-6, Milwaukee

American Pain Society

Plenary sessions and panel symposia during the APS conference will dwell on new research to discover safer pain medications and on promising non-pharmaceutical interventions for chronic pain. Speakers will share emerging science and how it translates to clinical practice. Officials from the National Institutes of Health will provide updates on the NIH HEAL Initiative (Helping to End Addiction Long-term) and its potential to significantly advance pain science.

Released:
15-Feb-2019 9:40 AM EST
Embargo will expire:
21-Feb-2019 5:00 PM EST
Released to reporters:
15-Feb-2019 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Feb-2019 5:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

color-without-R-core-standard.png

Article ID: 708149

Weight Cycling Does Not Adversely Affect Cardiovascular Outcomes in Women with Suspected Myocardial Ischemia

University of Alabama at Birmingham

Study suggests that weight loss, even if associated with intermittent weight gain, is worthwhile in that there appears to be no harm and possible benefit in terms of cardiovascular outcomes.

Released:
15-Feb-2019 9:00 AM EST
OSA_daytimesleepiness.jpg
  • Embargo expired:
    15-Feb-2019 12:00 AM EST

Article ID: 707952

OSA Patients with Excessive Daytime Sleepiness at Greatest Risk for Cardiovascular Disease

American Thoracic Society (ATS)

Adults with obstructive sleep apnea (OSA) who experience excessive sleepiness while awake appear to be at far greater risk for cardiovascular diseases than those without excessive daytime sleepiness, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released:
12-Feb-2019 4:00 PM EST

Article ID: 708144

Dr. Adriana Di Polo Awarded the 2019 Shaffer Prize from Glaucoma Research Foundation

Glaucoma Research Foundation

For her research project seeking a new treatment to restore vision in glaucoma patients, Adriana Di Polo, PhD, professor of neuroscience at the University of Montreal, was awarded the 2019 Shaffer Prize for Innovative Glaucoma Research. The 2019 Shaffer Prize was presented on January 31st during ceremonies at the Glaucoma 360 Annual Gala at the Palace Hotel in San Francisco.

Released:
14-Feb-2019 6:05 PM EST
asn_logo_helv.jpg
  • Embargo expired:
    14-Feb-2019 5:00 PM EST

Article ID: 707764

Kidney Failure Patients Face Higher Risk of Cancer Death

American Society of Nephrology (ASN)

In a population-based study, both patients on dialysis and those who received kidney transplants experienced over 2.5-times higher risks of cancer death than age- and sex-matched individuals without kidney failure.

Released:
8-Feb-2019 8:05 AM EST
Embargo will expire:
19-Feb-2019 11:00 AM EST
Released to reporters:
14-Feb-2019 4:30 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Feb-2019 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results 1120 of 107837

Chat now!